Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

Overview

cited authors

Liu, Hui; Shen, Qi; Chang, Chung-Che; Hu, Shimin

authors

Chang, Chung-Che Jeff, MD, PhD, FCAP

Publication Date

December 23, 2021

webpage

Web of Science

published in

FRONTIERS IN ONCOLOGY Journal

Research

keywords

BCL2
BCL6
High-grade B-cell lymphoma
MYC
lineage switch
plasmablastic lymphoma
plasticity
therapeutic resistance

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.